Showing 151-160 of 322 results for "".
Journal Club: Pediatric Treatment Adherence
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-pediatric-treatment-adherence/32401/Practical Dermatology Editorial Board members Lawrence Eichenfield, MD, FAAD, Jason Hawkes, MD, MS FAAD, discuss the article "Treatment Adherence in Pediatric Atopic Dermatitis: A Systemic Review," from Pediatric Dermatology as well as their favorite strategies for treatment adherence and the impactWhat Will Be Our Legacy?
https://practicaldermatology.com/topics/practice-management/what-will-be-our-legacy/21434/Practical Dermatology® Magazine Welcomes Neal Bhatia, MD, FAAD as Co-Chief Medical EditorJournal Club: What's New in Pathogenesis and Treatment of Atopic Dermatitis
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-whats-new-in-pathogenesis-and-treatment-of-atopic-dermatitis/26247/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, talks with Jason E. Hawkes, MD, a dermatologist practicing in the Sacramento area, and a member of the Practical Dermatology Editorial Board, about the latest research on the pathogenesis of and treatment targets for atopic dermatitis (AD).Therapeutics Update: Exploring Current Treatments for Diverse Conditions
https://practicaldermatology.com/topics/therapeutics-update/therapeutics-update-exploring-current-treatments-diverse-conditions/24562/Chief Medical Editor Neal Bhatia, MD, FAAD, and the Practical Dermatology® team convened an expert roundtable to discuss therapeutic treatment strategies for vitiligo, alopecia areata, hidradenitis suppurativa, and chronic spontaneous urticaria—the latest options, what has fallen out of favor, challAnti-Semitism and Dermatologists
https://practicaldermatology.com/columns/editors-message/anti-semitism-and-dermatologists/23988/(A Personal Narrative from the Editor)The Safety of New Systemics
https://practicaldermatology.com/issues/practicaldermatology-com-march-2025/the-safety-of-new-systemics/33159/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, provides an overview of the safey of systemic therapies such as JAK inhibitors and other similar drugs, giving dermatologists a high-level look at what they need to help clinical decision-making.Help Me Help Replace You
https://practicaldermatology.com/topics/editorial/help-me-help-replace-you/24564/Chief Medical Editor Neal Bhatia, MD, FAAD, reflects on the mix of veteran talent and youthful rising stars that work together to succeed and to evolve in the dermatology field.ISDPA: Society Leadership Discusses Issues Facing PAs
https://practicaldermatology.com/conferences/isdpa-midwest-derm-2024/isdpa-society-leadership-discusses-issues-facing-pas/27067/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, talks about the latest issues facing physicians assistants with Illinois Society of Dermatology Physician Assistants (ISDPA) leaders Jang-Mi Johnson, PA-C; Sarah Anderson, PA-C; Jordan Stemer, PA-C; and Andrew Mastro, PA-C, at the ISDThe Landscape for Vitiligo: An Interview with Larry Green, MD
https://practicaldermatology.com/topics/pigmentary-disorders/the-landscape-for-vitiligo-an-interview-with-larry-green-md/24209/Practical Dermatology® Chief Medical Editor Neal Bhatia, MD, FAAD, talked with Larry Green, MD, a board-certified dermatologist in private practice in Rockville, Maryland, about the latest in vitiligo treatment and what practitioners can tell their patients about recent advances in treatment for thiWhy Assessing Vitiligo Activity is Critical for Limiting Spread
https://practicaldermatology.com/conferences/maui-derm-2024/why-assessing-vitiligo-activity-is-critical-for-limiting-spread/20248/Chief Medical Editor Neal Bhatia, MD talks with “Mr. Vitiligo Himself,” John E. Harris, MD, PhD about the importance of determining whether vitiligo patients are active or stable in order to “shut off” spreading as soon as possible.